Altimmune ALT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's net change in cash?
- Altimmune (ALT) reported net change in cash of $53.84M in Q1 2026.
- How has Altimmune's net change in cash changed year-over-year?
- Altimmune's net change in cash increased by 342.1% year-over-year, from $12.18M to $53.84M.
- What is the long-term trend for Altimmune's net change in cash?
- Over 3 years (2021 to 2024), Altimmune's net change in cash has grown at a 11.7% compound annual growth rate (CAGR), from $74.38M to -$103.64M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.